Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

Journal: Journal of Experimental Medicine

Published: 2020-02-03

DOI: 10.1084/jem.20191009

Affiliations: 6

Authors: 22

Institutions	Authors	Share
Laboratory of Experimental Immunology, Osaka University, Japan		0.48
Faculty / Graduate School of Medicine, Akita University, Japan		0.20
Faculty / Graduate School of Medicine, Mie University, Japan		0.14
Klinik für Onkologie und Hämatologie, Krankenhaus Nordwest GmbH, Germany		0.09
Department of Hematology and Oncology, Kyoto University, Japan		0.05
Faculty / Graduate School of Medicine, Kyoto University, Japan		0.05

Return

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free